The answer is short and simple: We dont know
The concept is straightforward: if BPC-157 primarily promotes angiogenesis and GHK-Cu primarily supports osteoblast attachment and collagen synthesis, combining them might address multiple aspects of bone healing simultaneously
Herein, PDA acts as a foundational template that facilitates the growth of a Pt shell on the surface of its nanospheres, leading to the formation of the PDA@Pt nanomedicine
We stated in the proposed rule that while these elements help to identify the hospital, interested parties have told us that they are inadequate to facilitate comparing hospital MRF data with other datasets that include hospital-related information and that a standard identifier would bolster these efforts
It should also look at formulation development costs, the complexity of the regulatory route, and the time it takes to get the product to market
You can find my go-to green smoothie recipe here